People who suffer from psoriasis experience scaly, painful rashes and flaking skin. Most people see these breakouts on their knees, elbows, torso or scalp. Scientists aren’t sure what causes psoriasis ...

LAVAL, QC / ACCESSWIRE / December 18, 2023 / Bausch Health, Canada, part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), ("Bausch Health" or the "Company") today announced that DUOBRII™ (0.01% ...

Summer invites us to embrace outdoor fun and sunshine. But for those managing psoriasis, it also signals a time to be mindful of skin health. As temperatures rise and activities shift outdoors, you ...

Teligent, a speciality generic drug company located in Buena, N.J., recently earned Food and Drug Administration approval for its clobestasol propionate lotion 0.05%. The lotion, intended to treat ...

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the treatment of plaque psoriasis of the scalp and body in adult and pediatric ...

HUNTINGTON BEACH, Calif. — The US Food and Drug Administration (FDA) approvals of tapinarof 1% cream and roflumilast 0.3% cream as treatment options for patients with plaque psoriasis came more than 1 ...

Oct 8 (Reuters) - Bausch Health Cos said on Monday it received tentative approval from the U.S. health regulator to market its plaque psoriasis lotion, Bryhali. The final approval from the Food and ...

Psoriasis can increase skin infection risk due to effects from the condition and its treatments. Learn about potential infections, symptoms, and preventive measures.